Immunogenicity and safety of co-administration of adjuvanted respiratory syncytial virus prefusion F protein vaccine with 20-valent pneumococcal conjugate vaccine in adults aged >/=60 years: a randomized, non-inferiority trial. (academic.oup.com)

Authors: Leroux-Roels I … Van der Wielen M Journal: Clinical Infectious Diseases Published: 2026-04-13 DOI: https://doi.org/10.1093/cid/ciag250